CORRESP Filing
Trailblazer Acquisition Corp.
Date: Aug. 25, 2025 · CIK: 0002075310 · Accession: 0001213900-25-080202
AI Filing Summary & Sentiment
File numbers found in text: 333-288651
Show Raw Text
CORRESP
1
filename1.htm
VIA EDGAR
August 25, 2025
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, NE
Washington, D.C. 20549
Attention: Ms. Stacie Gorman
Re:
Trailblazer Acquisition Corp.
Amendment No. 1 to Registration Statement
on Form S-1
Filed August 11, 2025
File No. 333-288651
Dear Ms. Gorman:
Trailblazer Acquisition Corp.
(the " Company ") hereby submits its response to the comment letter received from the staff (the " Staff ")
of the U.S. Securities and Exchange Commission (the " Commission ") on August 23, 2025 (" Comment Letter ")
relating to the Amendment No. 1 to the Registration Statement on Form S-1, submitted by the Company with the Commission on August 11,
2025 (the " Amendment No. 1 ").
The Company has publicly filed
via EDGAR its Amendment No. 2 to the Registration Statement on Form S-1 (the " Amendment No. 2 "), which reflects the
Company's responses to the Comment Letter received from the Staff and certain updated information. For the Staff's convenience,
we have repeated below the Staff's comments in bold and have followed each comment with the Company's response.
Amendment No. 1 to Registration Statement on Form S-1
Cover Page
1. We note your response to prior comment 1. Please expand your disclosure here and on pages 10 and 111 to clarify that the
cashless exercise of your warrants may result in material dilution. Please refer to Items 1602(a)(3), 1602(b)(6), and 1603(a)(6) of Regulation
S-K.
Response: The Company acknowledges
the Staff's comment and has added the additional disclosure regarding potential dilution from conversion of the working capital
loans to the cover page and to pages 10, 11, 111 and 112 of Amendment No. 2.
Risk Factors, page 43
2. We note your response to prior comment 6. Please add risk factor disclosure to address the risks associated with no member
of your management having prior SPAC experience.
Response: The Company acknowledges
the Staff's comment and added the additional risk factor to the summary on page 42 and on page 73 of the Amendment No. 2.
Management
Executive Officer and Director Compensation, page 140
3. We note your response to prior comment 5. Please revise your disclosure in this section to reflect the shares to be given
to your independent directors and chief financial officer. Please refer to Item 402(r)(3) of Regulation
S-K.
Response: The Company acknowledges
the Staff's comment and added disclosure on page 140 of the Amendment No. 2.
Part II. Information not Required in Prospectus
Item 16. Exhibits and Financial Statement Schedules, page II-2
4. We note your response to prior comment 7. We note that Exhibit 10.3 does not link to your Registration Rights Agreement, but instead
to a Private Placement Warrants Purchase Agreement. Please update to provide the correct exhibits and hyperlinks. Please refer to Item
601(a)(2) of Regulation S-K.
Response: The Company acknowledges
the Staff's comment and has updated the correct exhibits and corrected the hyperlinks to the referenced exhibits on page II-2 of
the Amendment No. 2.
***
We thank the Staff for its review of the foregoing.
If you have further comments, please feel free to contact to our counsel, Stuart Neuhauser at sneuhauser@egsllp.com or by telephone at
(212) 370-1300.
Sincerely,
/s/ Eric Semler
Eric Semler, Chief Executive Officer
cc: Ellenoff Grossman & Schole LLP